Looking for exceptional Pharmacokinetic, Bioequivalent, Toxicokinetic or Residual studies?

Thanks to our advanced technology, techniques, and highly sensitive ICP/MS tech, QUINTA-ANALYTICA’s bioanalytical department is capable of conducting elemental analyses of extremely minute trace elements in biological matrices such as urine, plasma, blood serum & tissues.

With very low detection limits in the order of parts per billion, we can determine the given element not only in terms of total concentration, but also the form in which the monitored element is contained in the given matrix (using speciation analysis). This is essential for assessing the efficacy of drugs or dietary supplements containing trace elements.

A perfect example: a methodology we’re currently establishing to determine serum iron after administration of a colloidal form of iron (i.e. Ferric carboxymaltose) used in the treatment of anaemia. Our analyses can be used to determine both total iron in the blood serum plus its individual forms (labile iron, iron bound to transferrin, colloidal iron).

We think that’s pretty cool!

Curious to know how we do it, or more about our services? Get in touch.

Additional News

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.